264|1126|Public
30|$|There {{are many}} {{analytical}} methods available for estimation of glimepiride in biological samples and pharmaceutical preparations. To our knowledge, {{there is no}} specific reverse-phase high-performance liquid chromatography (RP-HPLC) method for estimation of glimepiride and its <b>dissolution</b> <b>study</b> in self-nanoemulsifying powder (SNEP) formulation.|$|E
40|$|Two simple, economical, precise, and {{accurate}} methods are described for the simultaneous determination of Paracetamol and Diclofenac in combined tablet dosage form. The first method is first- order derivative zero crossing method. The first order derivative absorption at 275. 6 nm (zero cross point of Diclofenac) {{was used for}} Paracetamol and 242. 69 nm (zero cross point of Paracetamol) for Diclofenac. The second one is simultaneous equation method in application to <b>dissolution</b> <b>study.</b> Simultaneous equation method was successfully applied to carry out <b>dissolution</b> <b>study</b> of commercial tablet formulation by using USP type II dissolution test apparatus. The solvent used is pH 6. 8 phosphate buffer. Linearity range was 2 - 10 µg/ml and 5 - 25 µg/ml for Paracetamol and Diclofenac respectively. The methods were validated with respect to linearity, precision and accuracy...|$|E
40|$|The main {{objective}} of present work {{was to develop}} simple spectrophotometric multicomponent method of analysis i. e. simultaneous equation method. Tenofovir disoproxil fumarate & Emtricitabine was first approved in US in July 2003 and is indicated for adults aged > or = 18 years. This method is used for <b>dissolution</b> <b>study</b> of Tenofovir disoproxil fumarate and Emtricitabine in combined tablet dosage form. As per USFDA guidelines, <b>dissolution</b> <b>study</b> {{was carried out in}} 900 mL 0. 01 N HCl. <b>Dissolution</b> <b>study</b> was carried out using a USP Type 2 (Paddle) apparatus at a stirring rate of 50 rpm for 45 minutes as per USFDA guidelines. Tenofovir disoproxil fumarate and Emtricitabine showed 258 and 286 nm as λmax in 0. 01 N HCl respectively. The drug release from tablet was evaluated by developed spectroscopic methods i. e. simultaneous equation method. At the end of 45 minutes, % Cumulative drug release of Emtricitabine & Tenofovir disoproxil fumarate was found to be 104. 9 & 98. 8 % based on developed method. The developed method was found to be simple, rapid, less tedious & economical compare to other reported methods in literature. The developed method can be a good alternative method for quality control testing of Emtricitabine & Tenofovir disoproxil fumarate in combined dosage form. Keywords: Tenofovir disoproxil fumarate, Emtricitabine, Simultaneous Equation method, Dissolution, USFD...|$|E
40|$|Aim: The aim {{of present}} work {{was to develop}} {{microspheres}} of Famotidine using natural bioenhancers to achieve sustained action for treatment of Peptic ulcer. Method: Ionotropic gelation method {{was used for the}} development of microspheres. During preliminary trials, optimum concentration of all the ingredients were selected through entrapment efficiency, <b>dissolution</b> <b>studies</b> method. An optimized formulation was prepared and evaluated for mean particle size, percentage buoyancy, <b>dissolution</b> <b>studies,</b> micromeritic studies. Microscopic characteristics of the optimized formulation were studied using Scanning electron microscopy. Stability studies and releae kinetics were studied for the optimized formulation. Result: After preliminary trials, F 5, F 9, F 11 and F 13 were {{selected on the basis of}} entrapment efficiency and <b>dissolution</b> <b>studies</b> and their concentrations were utilised for preparing optimized formulation. Optimized Formulation of famotidine containing bio enhancers showed excellent floatability, good buoyancy, better micromeritics properties and increment in drug release. It was observed that release follows first order kinetics and good stability was observed for 2 months during stability studies. Conclusion: Current results indicate a promising approach of Famotidine microspheres, as an alternative for treating Peptic ulcer. Keywords: Famotidone, Bioenhancers, <b>Dissolution</b> <b>studies,</b> Microspheres, Peptic ulce...|$|R
30|$|The {{validated}} RP-HPLC method may {{be successfully}} applied for assay, <b>dissolution</b> <b>studies,</b> bio-equivalence studies, {{as well as}} routine analysis in pharmaceutical industries.|$|R
40|$|Without {{disturbing}} the observed processes, the MRI methods {{combined with the}} <b>dissolution</b> <b>studies</b> {{provide insight into the}} phenomena occurring when the dosage form comes into contact with aqueous fluids. The MR images allow one to observe the solvent penetration into the hydrophilic matrix and the hydrogel formation. The data obtained in the MRI studies complement information obtained from the <b>dissolution</b> <b>studies.</b> The analysis of MR images may support the explanation of differences in the drug-releasing or floating properties of HBS...|$|R
40|$|The present {{investigation}} deals with formulation of nicotinamide-based co-crystals of fenofibrate by different methods and solid-state {{characterization of the}} prepared co-crystals. Fenofibrate and nicotinamide as a coformer in 1 : 1 molar ratio were used to formulate molecular complexes by kneading, solution crystallization, antisolvent addition and solvent drop grinding methods. The prepared molecular complexes were characterized by powder X-ray diffractometry, differential scanning calorimetry, Fourier transform infrared spectroscopy, nuclear magnetic resonance spectroscopy and in vitro <b>dissolution</b> <b>study.</b> Considerable improvement in the dissolution rate of fenofibrate from optimized co-crystal formulation was due to an increased solubility that is attributed to the super saturation from the fine co-crystals is faster because of large specific surface area of small particles and prevention of phase transformation to pure fenofibrate. In vitro <b>dissolution</b> <b>study</b> showed that the formation of co-crystals improves the dissolution rate of fenofibrate. Nicotinamide forms the co-crystals with fenofibrate, theoretically and practically...|$|E
40|$|Purpose: The aim of {{the present}} {{investigation}} was preparation and characterization of sirolimus solid dispersions by solvent evaporation technique to improve its dissolution properties. Methods: Polyvinylpyrrolidone (PVP), Poloxamer 188 and Cremophore RH 40 were used to prepare the solid dispersions of sirolimus. In vitro <b>dissolution</b> <b>study</b> using USP type I apparatus, were performed in distilled water (containing SLS 0. 4...|$|E
40|$|Abstract: Experimental embolic {{particles}} {{based on}} a novel zinc-silicate glass system have been biologically evaluated for potential consideration in transcatheter arterial embolization procedures. In addition to controlling the cytotoxicity and haemocompatibility for such embolic particles, its glass structure may mediate specific responses via dissolution in the physiological environment. In a 120 h in-vitro <b>dissolution</b> <b>study,</b> ion release levels forJ. Funct. Biomater. 2013, 4 9...|$|E
40|$|Ciprofloxacin, {{commonly}} used in India as an anti-microbial for prolonged use in chronic and non-specific indications, may affect the bioavailability of the drug. The drug prescribed is commonly taken with multivitamins, calcium and milk. A simple and reliable analytical methodology obtaining a correlation with in vivo urinary excretion studies using UV and HPLC and in vitro <b>dissolution</b> <b>studies</b> (IVIVC) has shown {{a significant increase in}} elimination rate of ciprofloxacin co-administered with multivitamins, calcium and milk. Appreciable IVIVC results proved that <b>dissolution</b> <b>studies</b> could serve as an alternative to in vivo bioavailability and also support bio-waivers...|$|R
30|$|Most of {{the earlier}} methods are not ideal since they are time-consuming, have high limits of detections, use of surplus organic solvents, strenuous sample preparation, involve {{expensive}} instrumentation and long chromatographic run times. In recent years, <b>dissolution</b> <b>studies</b> have emerged in the pharmaceutical field as a very imperative tool based on the reality that for a drug to be absorbed and available to the systemic circulation, it must previously be solubilized. Consequently, the <b>dissolution</b> <b>studies</b> are used not only to evaluate batch-to-batch consistency of drug release from solid dosage forms, but also in several crucial stages of formulation development, for screening and proper assessment of different formulations. Moreover, the information obtained from in vitro <b>dissolution</b> <b>studies</b> {{has been used for}} the successful characterization of the in vivo behavior of drugs. To our knowledge, there is no specific RP-HPLC method for quantification and assessing dissolution rate profile for GLM in self-nanoemulsifying powder (SNEP) formulation.|$|R
40|$|In lieu of an abstract, here is {{the article}} 2 ̆ 7 s first paragraph: Bioavailability of multi-vitamins as dietary {{supplements}} {{has always been a}} concern. <b>Dissolution</b> <b>studies</b> have been successfully used to predict drug release of bioactive molecules, but with vitamins there are some exceptions. United State Pharmacopoeia (USP) defines the dissolution requirements of multi-vitamin supplements based on the composition and type of dosage form. As oil-soluble vitamins do not meet the criterion of “dissolution”, the performance of dosage forms containing such vitamins is evaluated by disintegration <b>studies</b> primarily. <b>Dissolution</b> <b>studies</b> are not applicable for such dosage forms [1]...|$|R
40|$|Copolymer of {{vinyl acetate}} and maleic anhydride, poly (vinyl acetate-co-maleic anhydride) was {{prepared}} by precipitation polymerization and characterized. Paracetamol was crystallized in presence of different concentrations of poly (vinyl acetate-co-maleic anhydride). Crystals {{were characterized by}} sieve analysis, solubility and <b>dissolution</b> <b>study.</b> Crystallization of paracetamol in presence of poly (vinyl acetate-co-maleic anhydride) caused a marked enhancement in its dissolution rate with increase in concentration of poly (vinyl acetate-co-maleic anhydride) in crystallization medium...|$|E
40|$|The aim {{of present}} work was {{to improve the}} {{solubility}} of a poor water soluble drug, cinnarizine, by using solid dispersion technique. Cinnarizine is a H 1 -receptor antagonist and widely used {{in the treatment of}} motion sickness, vomiting and vertigo. In the present work solid dispersion of cinnarizine were prepared with a polyethylene glycol 4000 and polyvinyl pyrrolidone K 30 by using solvent evaporation and fusion method in the 1 : 1, 1 : 2 and 1 : 3 ratio of drug and carrier respectively. Solid dispersion of cinnarizine was evaluated for drug content, Infrared spectroscopy and In vitro <b>dissolution</b> <b>study.</b> The solid dispersion with PEG and PVP exhibited enhanced dissolution rate of cinnarizine. IR spectra revealed no chemical incompatibility between drug and carrier. The dissolution of the solid dispersion was carried out in 0. 1 N HCl. The In vitro <b>dissolution</b> <b>study</b> showed {{a significant increase in the}} release rate of cinnarizine in solid dispersion of cinnarizine with polyvinyl pyrrolidone K 30 in the ratio 1 : 3 prepared by solvent evaporation method...|$|E
40|$|The {{purpose of}} this study is to enhance {{solubility}} and dissolution rate of poorly water soluble drug. Several techniques such as micronisation, cyclodextrin-complexation, use of surfactants, solubilizers and super disintegrants, solid dispersion in water soluble and water dispersible carriers, microemulsions and self emulsifying micro and nano disperse systems have been used to enhance the solubility and dissolution rate of poorly water soluble drugs. Among the various approaches solid dispersion technique is most widely used. Cefdinir is a drug of choice for solubility and dissolution enhancement. Solid dispersions were prepared by solvent evaporation method and melt fusion method using polyethylene glycol 3350 and PVP-K 30 as hydrophilic carriers. The prepared solid dispersions were evaluated in terms of drug content, % yield and in-vitro <b>dissolution</b> <b>study.</b> In-vitro release profiles of all dispersions were comparitively evaluated and also studied against pure cefdinir. The results obtained showed that the rate of dissolution of cefdinir was considerably improved when formulated in solid dispersions as compare to pure drug. Key Words: Poorly water drug, Solvent evaporation, In-vitro <b>dissolution</b> <b>study,</b> Cefdinir...|$|E
40|$|Paracetamol/Eudragit RS, paracetamol/ethylcellulose, and paracetamol/cellulose acetate pellets of {{different}} drug/polymer ratios (w/w) were {{prepared by the}} dissolution/solvent evaporation technique. These pellets were then characterized by particle size distribution analysis, ultraviolet (UV) spectroscopy, differential thermal analysis, and scanning electron microscopy (SEM). Hard gelatin capsules were filled with each particle size fraction of these pellets, and in vitro <b>dissolution</b> <b>studies</b> were performed to verify the capability of each series of pellets to control drug release. Pellets were spherical, presented a polynucleated microcapsule structure, and under certain experimental conditions, the yield of the preparation process reached very high values. The <b>dissolution</b> <b>studies</b> pointed out the slow paracetamol release from these pellets...|$|R
40|$|This work {{reports the}} {{validation}} of an analytical UV spectrophotometric method to assay acyclovir in hydrophilic matrices (assay and <b>dissolution</b> <b>studies).</b> The method was linear {{in the range}} between 2. 5 - 20 µg mL- 1, presenting a good correlation coefficient (r = 0, 9999). Precision and accuracy analysis showed low relative standart deviation (< 2. 0 %) and a good recoveries percentual (98. 9 - 100 %). The procedure was linear, accurate, and robust. The method is simple and cheap. It does not use polluting reagents and can be applied in <b>dissolution</b> <b>studies,</b> being an adequate alternative to assay acyclovir in hydrophilic matrices tablets...|$|R
30|$|The {{proposed}} {{method was}} found to be simple, precise, suitable, and accurate for quantification of glimepiride {{as an alternative to the}} existing methods for the routine analysis of glimepiride in pharmaceutical formulations and in vitro <b>dissolution</b> <b>studies.</b>|$|R
40|$|In {{the course}} of <b>dissolution</b> <b>study</b> of spent nuclear fuels, {{destructive}} analyses of actinides and fission product nucl ides formed in PWR spent fuels of which mean assembly burnups ranged from 6. 9 to 34. 2 GWd/t wered carried out. The measurements of thirty nucl ides of uranium, transuranium and fission products elements were done by mass spectrometry, u-ray and 7 -ray spectrometry after dissolution of round sliced pellets by nitric acid solution. The amounts of nucl ides measured were compared with those calculated by two burnup codes, 0 RIGEN 2 and SRAC-FPGS...|$|E
40|$|Modified-release multiple-unit tablets of {{loratadine}} and pseudoephedrine hydrochloride {{with different}} release profiles were prepared from the immediate-release pellets comprising the above two drugs and prolonged-release pellets containing only pseudoephedrine hydrochloride. The immediate-release pellets containing pseudoephedrine hydrochloride {{alone or in}} combination with loratadine were prepared using extrusion–spheronization method. The pellets of pseudoephedrine hydrochloride were coated to prolong the drug release up to 12  h. Both immediate- and prolonged-release pellets were filled into hard gelatin capsule and also compressed into tablets using inert tabletting granules of microcrystalline cellulose Ceolus KG- 801. The in vitro drug <b>dissolution</b> <b>study</b> conducted using high-performance liquid chromatography method showed that both multiple-unit capsules and multiple-unit tablets released loratadine completely within a time period of 2  h, whereas the immediate-release portion of pseudoephedrine hydrochloride was liberated completely within the first 10  min of <b>dissolution</b> <b>study.</b> On the other hand, the release of pseudoephedrine hydrochloride from the prolonged release coated pellets was prolonged up to 12  hr and followed zero-order release kinetic. The drug dissolution profiles of multiple-unit tablets and multiple-unit capsules {{were found to be}} closely similar, indicating that the integrity of pellets remained unaffected during the compression process. Moreover, the friability, hardness, and disintegration time of multiple-unit tablets were found to be within BP specifications. In conclusion, modified-release pellet-based tablet system for the delivery of loratadine and pseudoephedrine hydrochloride was successfully developed and evaluated...|$|E
40|$|Abstract: The {{objective}} of the present investigation {{was to develop a}} gastroretentive tablets for verapamil hydrochloride (verapamil-HCl) using different hydrocolloid polymers including Carbopol (CP 934 P; CP 940 P), Hydroxypropylmethylcellulose (HPMC K 4 M; HPMC K 15 M; HPMC E 15) and Xanthan gum by direct compression technology. The tablets were evaluated for the physicochemical parameters such as weight variation, thickness, friability, hardness, drug content, in vitro buoyancy studies, swelling index study, in vitro dissolution studies. The prepared tablets exhibited satisfactory physico-chemical characteristics. Tablet bouncy was achieved by adding an effervescent mixture of sodium bicarbonate and anhydrous citric acid. The in vitro dissolution studies were carried out in a USP XXII apparatus 2 in 0. 1 N HCl. All the gastroretentive tablets showed good in-vitro buoyancy. The tablet swelled radially and axially during in-vitro buoyancy studies. The selected tablets (F 6) containing Xanthan gum released approximately 97. 89 % drug in 24 h in vitro <b>dissolution</b> <b>study,</b> while the buoyancy lag time was 24. 6 ± 3. 2 second and the tablet remained buoyant for> 24 h. Zero order and non-Fickian release transport was confirmed as the drug release mechanism for the selected tablets (F 6). Tablets (F 6) showed no significant change in physical appearance, drug content, total buoyancy time or in vitro <b>dissolution</b> <b>study</b> after storage at 45 °C/ 75 % RH for three months...|$|E
40|$|International audienceUsually, <b>dissolution</b> <b>studies</b> of soluble powders do {{not take}} into account the {{existence}} of the size distribution of particles. It is shown that this concept is of fundamental interest in the prevision of particular aspects of the dissolution process, like the total time required for complete <b>dissolution.</b> The <b>study</b> of the evolution of grain size distribution was carried out with a laser beam scattering sizer. A numerical simulation was set up based on the results obtained...|$|R
40|$|A new technique, {{employing}} the scanning electrochemical microscope, is {{proposed for the}} investigation of dissolution kinetics under conditions of both well defined mass transfer and surface structure. Preliminary <b>dissolution</b> <b>studies</b> on copper sulfate pentahydrate single crystals demonstrate {{the validity of the}} technique...|$|R
40|$|The {{objective}} of {{present study was}} to develop and validate an analytical method for quantitative determination and <b>dissolution</b> <b>studies</b> of glimepiride in tablets. The glimepiride shows absorption maxima at 225 nm and obeyed Beer's law in the range of 6. 0 – 14. 0 µg/mL. The limit of detection and limit of quantitation were 0. 06, and 0. 17 µg/mL respectively. Percentage recovery of glimepiride for the proposed method ranged from 99. 32 to 100. 98 % indicating no interference of the tablet excipients. It was concluded that the proposed method is simple, easy to apply, economical and used {{as an alternative to the}} existing spectrophotometric and non-spectrophotometric methods for the routine analysis of glimepiride in pharmaceutical formulations and in vitro <b>dissolution</b> <b>studies...</b>|$|R
40|$|In {{the present}} study {{an attempt was made}} to prepare {{acyclovir}} floating tablets. Acyclovir floating tablets (200 mg) were prepared by direct compression method using HPMC, sodium carboxy methyl cellulose and carbopol with an effervescent base (sod. Bicarbonate and citric acid). FTIR study confirmed the absence of any drug/polymer/excipients interactions. The prepared floating tablets were evaluated for hardness, weight variation, thickness, friability, drug content uniformity, buoyancy lag time, total floating time, swelling index and in vitro dissolution studies. Among all the 12 formulations F 1, F 2, F 3, F 4, F 5, F 6, F 10, F 11, F 12 showed good floating property while formulations F 7, F 8, F 9 showed moderate floating while all the 12 formulations showed controlled drug release. Stability studies were carried out for F 4 and F 10, both the formulations showed good stability. It was observed that F 4 and F 10 gave maximum drug release upto 97. 17 % within 24 hrs. SEM study indicates that both the tablets F 4 &F 10 have smooth and uniform surface before the <b>dissolution</b> <b>study,</b> but after the <b>dissolution</b> <b>study,</b> the Tablet F 4 which was prepared withsod. CMC has shown erosion of the polymer matrix. But the Tablet F 10 have shown spongy like structure, the matrix was swollen and pores were created...|$|E
40|$|In {{the present}} investigation, two novel gum {{mixtures}} were evaluated as controlled release polymer. The ghatti gum obtained from Anogeissus latifolia and Konjac glucomannan from Amorphophallus konjac was evaluated as base polymer for controlled delivery of model drug diclofenac sodium. The prepared synergistically acting gums were evaluated for compatibility study using FT-IR. The diclofenac sodium tablets were evaluated for hardness, friability, weight variation and drug content. The in vitro <b>dissolution</b> <b>study</b> {{confirmed that the}} controlled release behavior is mainly due to konjac glucomannan proportion and optimum concentration ratio for ghatti: konjac glucomannan was 30 : 70...|$|E
40|$|In {{the present}} work {{attempts}} were made to prepare dispersible tablets of Amoxicillin trihydrate and Dicloxacillin sodium by direct compression technique to enhance patient compliance. The three superdisintegrents used in the study were Crosscarmellose sodium, Crospovidone and Sodium starch glycolate. Tablet batches having superdisintegrents at different concentrations (20, 30 and 60 gm) level were prepared. The prepared batches of tablets were evaluated for uniformity of weight, thickness, hardness, friability, disintegration test and invitro – <b>dissolution</b> <b>study.</b> Tablet containing combination of Crosscarmellose sodium and Crospovidone showed excellent invitro disintegration time and drug release as compared to other formulations...|$|E
30|$|The <b>dissolution</b> <b>studies</b> of GLM-loaded SNEP {{formulation}} {{was performed}} in a USP-II dissolution test apparatus (DS 8000, LABINDIA, Mumbai, India). The <b>dissolution</b> <b>studies</b> were conducted according to the dissolution procedure recommended for single-entity products in 900  mL of 0.1  N HCl (75  rpm). The temperature of the cell was maintained at 37 [*]±[*] 0.5  °C by using a thermostatic bath. At predetermined time intervals (0, 5, 10, 15, 30, 60, 90, and 120  min) an aliquot (5  mL) {{of the sample was}} withdrawn from each vessel and immediately replaced with an equal volume of fresh medium to maintain sink conditions. The samples collected were filtered through a membrane filter (0.45  μm) and further analyzed by HPLC. In order to obtain the dissolution profile, the cumulative percentage of drug released was plotted against time (min).|$|R
30|$|The {{proposed}} {{method was}} rapid, accurate, precise, and sensitive for the quantification of GLM from its pharmaceutical dosage forms. The method {{relies on the}} use of simple working procedure; hence, this method can be routinely employed in quality control for analysis of GLM in pharmaceutical dosage forms and <b>dissolution</b> <b>studies.</b>|$|R
40|$|Weathering of {{minerals}} {{is an important}} geologic process that {{plays a significant role}} in much of the geochemistry of the earth’s surface, ranging from rock erosion rates to seawater chemistry. Laboratory <b>dissolution</b> <b>studies</b> are an important step in deriving models to help interpret environmental weathering. These studies help in th...|$|R
40|$|The {{purpose of}} the present {{investigation}} is to formulate gastroretentive floating tablets of Venlafaxine hydrochloride thus increasing its gastric residence time as well as bioavailability and therapeutic efficacy. Venlafaxine HCl having a short biological half-life of 4 h is eliminated quickly from the body leading to low therapeutic efficacy. Therefore a sustained release medication was advantageous so as to achieve the prolonged therapeutic effect and to reduce peak and valley effect in plasma concentration. This can be circumvented by formulating modified gastro retentive sustained release dosage forms which resides in the stomach for sufficient time to release the drug in vicinity of the absorption zone. Nine formulations of Venlafaxine HCl tablets were formulated by hot melt extrusion technique (HME) using three polymers like HPMC K 15 M, Xanthan gum and Guar gum in a various concentrations. Bees wax was used as a melting aid and sodium bicarbonate was used as a gas generating agent. The prepared tablets were evaluated for pre and post compression parameters, buoyancy time, floating lag time and in vitro <b>dissolution</b> <b>study.</b> In vitro <b>dissolution</b> <b>study</b> was carried out in pH 1. 2 buffer. It had been found that increase in polymer concentration diminishes drug release profile. The in vitro cumulative % drug release of nine formulations ranged from 88. 58 – 99. 19 with more than 12 h buoyancy. The in vitro drug release of optimised formulation followed Higuchi kinetics and the drug release mechanism was found to be non- fickian type...|$|E
40|$|In {{the present}} {{invention}} Fast dissolving tablets of Tizanidine {{were prepared for}} the immediate and effective treatment of muscle spam by adopting sublimation method. Formulations were evaluated for precompressional parameters such as angle of ripose, % compressibility and hausner’s ratio. Tablets were also subjected to post compress ional analysis for the parameters like hardness, friability, thickness, wetting time, water absorption ratio,in-vitro disintegration time and in-vitro <b>dissolution</b> <b>study.</b> The results obtained showed that quantity of camphor is significantly affecting the response variables. Stability study carried out as per ICH guidelines for three months and results reveled that upon storage disintegration time of tablets decreased significantly(p< 0. 05...|$|E
40|$|In {{the present}} {{research}} work mouth dissolving tablets of domperidone were developed with superdisintegrants like crospovidone, croscarmellose sodium and sodium starch glycollate in various concentrations like 3 %, 4 % and 6 % w/w by direct compression method. All formulations were evaluated for physical characteristics of compressed tablets such as weight variation, hardness, friability, content uniformity, in vitro disintegration time, wetting time and in vitro <b>dissolution</b> <b>study.</b> Among all, the formulation F 3 (containing 6 % w/w concentration of crospovidone) {{was considered to be}} the best formulation, having disintegration time of 9 s, wetting time of 15 s and in vitro drug release of 99. 22 % in 15 min...|$|E
40|$|Nifedipine is a BCS Class II drug {{used for}} {{treatment}} of hypertension and preterm labor. Large inter-patient variability in nifedipine absorption results in variable exposure among different patients. We conducted in vitro <b>dissolution</b> <b>studies</b> to compare nifedipine dissolution from immediate release (IR) capsules with different volumes of dissolution media. Results from <b>dissolution</b> <b>studies</b> were used to design a crossover study in healthy volunteers to evaluate the effect of coadministered water volume with nifedipine 10 mg IR capsules on nifedipine pharmacokinetics, especially absorption (Cmax, tmax, and AUC 0 - 6). <b>Dissolution</b> <b>studies</b> demonstrated that larger gastric fluid volumes result in enhanced nifedipine dissolution from 10 mg IR cosolvent capsules (73 vs. 17 % in 200 and 100 mL simulated gastric fluid, respectively, at 30 min). The pharmacokinetic crossover study in healthy volunteers (N[*]=[*] 6) did not show a significant effect of the water volume administered with the capsule (50 vs. 250 mL) on Cmax, tmax, or AUC 0 - 6 of orally administered nifedipine IR capsules (10 mg). However, administration of large water volumes resulted in lower variability in nifedipine Cmax (47 vs. 70 % for 250 and 50 mL, respectively). Administration of large water volumes with nifedipine 10 mg IR cosolvent capsules may reduce inter-individual variability in plasma exposure. Evaluation of similar effects in other BCS Class II drugs is recommended...|$|R
40|$|The aim {{of present}} study was to {{formulate}} and evaluate Gastroretentive bilayer floating tablets of Losartan potassium using direct compression technology. Bilayer floating tablets comprised two layers, i. e. immediate release and controlled release layers. The immediate release layer comprised Crospovidone as a super disintegrant and floating layer comprised Sodium carboxy methyl cellulose (SCMC), Metolose SR and Sodium alginate as the release retarding polymers. Sodium bicarbonate was used as a gas generating agent. The powder blends were evaluated for pre-compression parameters. Compressed tablets were further evaluated for hardness, friability, weight variation, dimensions, Drug Content Uniformity, In-vitro buoyancy and <b>dissolution</b> <b>studies.</b> All the formulations showed good results which were compliance with pharmacopoeial standards. In-vitro <b>dissolution</b> <b>studies</b> were performed in USP-XXIII dissolution test apparatus, type II (paddle method) in 1. 2 pH buffer. More than 99 % Losartan potassium of was released from the immediate release layer within 30 min. The results of <b>dissolution</b> <b>studies</b> indicated that formulation BFT 8 (drug to polymer[SCMC] 1 : 0. 25), the most successful of the study, exhibited drug release of approximately 98 % at 12 th hour with more than 12 h buoyancy with floating lag time of 93 seconds. An increase in drug release was observed on decreasing polymer ratio. The drug release mechanism of all the formulations was found to be Fickian diffusion-controlled drug release...|$|R
40|$|Fexofenadine is a {{selective}} histamine H 1 receptor antagonist, used for relief {{of the symptoms}} of allergy. However its aqueous solubility is very poor. Solid inclusion complexes of fexofenadine and &# 946;-cyclodextrin were prepared at the molar ratios of 1 : 1 and 1 : 2 by kneading, and coprecipitation methods to improve its solubility. Characterization of the complexes was performed using infrared spectroscopy, X-ray diffractometry, and in vitro <b>dissolution</b> <b>studies.</b> Fexofenadine was found to exhibit interaction with &# 946;-cyclodextrin both in solid and liquid state. Phase solubility studies indicated that fexofenadine forms a stable complex with &# 946;-cyclodextrin. Both IR spectroscopy and X-ray diffractometry studies indicated interaction of fexofenadine with &# 946;-cyclodextrin. Kneading method at 1 : 1 and co-precipitation method at 1 : 1 and 1 : 2 molar ratios showed significant interaction. In vitro <b>dissolution</b> <b>studies</b> confirmed the same results...|$|R
